Watery diarrhea, hypokalemia and achlorhydria syndrome which was described by Verner and Morrison (1) in 1958 for the first time (WDHA) is a rare cause of chronic secretory diarrhea arising from a vasoactive intestinal peptide (VIP) secreting tumor. In adults, the majority of WDHA syndrome arises from pancreatic islet cell adenoma and hyperplasia (2, 3). In contrast, it mostly arises from VIP secreting tumor originating from the neural crest cells in the adrenal medulla or sympathetic ganglia in children (4). In this article, a 15-month old female patient who could not be diagnosed despite investigations made in different centers because of watery diarrhea, severe malnutrition and abdominal distention which had been lasting for four months and who was later diagnosed with VIP secreting gangliobeuroblastoma localized in the right side was presented.
Vasoactive intestinal peptide releasing tumor which caused to chronic watery diarrhea and hypokalemia
). Follow-up urinary vanylmandelic acid (VMA) level was found to be normal. The patient whose diarrhea stopped completely and laboratory findings improved in the followup after the operation is being followed up without any problem over a one year period of time.
Discussion
Vasoactive intestinal peptide is a polypetide hormone which has widespread effects especially on the gastrointestinal system. It leads to secretory diarrhea, water and weight loss by preventing sodium, chlorine and water absorption in the intestines. It leads to hypokalemia by inducing potassium secretion in the intestines. It may cause to hypochlorhydria with inhibition of gastric acid secretion (4, 5) . In addition to these effects, it may cause to hypercalcemia by increasing bone resorption, flushing on the face by dilating blood vessels and hyperglycemia by way of hepatic glycogenolysis (2).
Patients with this syndrome specifically present with intensive secretory diarrhea and water and weight loss. Since the year of 1975 when the syndrome was described for the first time less than 70 pediatric cases have been defined. Ganglioneuroblastoma and ganglioneuroma have been found in most patients and neuroblastoma and neurofibroma have been found in a small number of cases. Vasoactive intestinal peptide-secreting tumors occur most frequently at the age of 1-3 years. The most common localization is the retroperitoneal area. This is followed by adrenal, thoracal, intestinal, paravertebral, sacral and cervical regions respectively (6). Our patient was 15 months old and the tumor originated from the adrenal medulla. In patients with unstoppable and unexplained secretory diarrhea, examination with USG which is a non-invasive method should be performed in terms of mass. In our patient, a mass was found in the right surrenal gland on abdominal USG. In VIP-secreting tumors which can not be determined by ultrasonographic examination, serum VIP levels should be evaluated primarily before performing detailed imaging procedures. In cases where the level of vasoactive intestinal peptide levels are high and the diagnosis can not be made by USG, the localization of the tumor can be determined by CT, MRI and angiography performed with the aim of screening (7). In addition, an increase in urinary catecholamine levels can be observed (8) . In our patient, catecholamine levels were found to be higher than normal.
This syndrome is a paraneoplastic syndrome which can be observed in neuroblastic tumors. Generally, differentiated tumors are associated with localized disease and a good prognosis (4, 9) . The definite treatment for watery diarrhea, hypokalemia and achlorhydria syndrome is removal of the tumor, if possible. If theraputic operation is not possible, tumor reduction surgery may alleviate the symptoms. In advanced cases, variable success can be obtained with somatostatin analogues and chemotherapy (10) . In our patient, the complaint of diarrhea regressed completely with full removal of the tumor.
Conclusively, childhood WDHA syndrome is a picture of secretory diarrhea, hypokalemia and hypochloremia. It may result in severe water loss, electrolyte and acid-base changes and chronic renal failure and mortality, if not treated. In presence of bulky, secretory diarrhea resistant to nonspecific teatment, plasma VIP levels should be investigated.
